An international perspective on pediatric psychopharmacology

References

• American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2007; 46: 894–921
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. Clinical practice guideline: Treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics 2001; 108: 1033–1044
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental DisordersFourth. American Psychiatric Association, Washington, DC 1994
   Google Scholar
• Bijl RV, de Graf R, Hiripi E. The prevalence of treated and untreated mental disorders in five countries. Health Affairs 2003; 22: 122–1333
   PubMed Web of Science ®Google Scholar
• Buitelaar JK, Barton J, Danckaerts M, Friedrichs E, Gillberg C, Hazell PL, et al. A comparison of North American versus non-North American ADHD study populations. European Child and Adolescent Psychiatry 2006; 15: 177–181
   PubMed Web of Science ®Google Scholar
• Canino G, Shrout PE, Rubio-Stipec M, Bird HR, Bravo M, Ramirez R, et al. The DSM-IV rates of child and adolescent disorders in Puerto Rico: Prevalence, correlates, service use, and the effects of impairment. Archives of General Psychiatry 2004; 61: 85–93
   PubMed Web of Science ®Google Scholar
• Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A. Prevalence and development of psychiatric disorders in childhood and adolescence. Archives of General Psychiatry 2003; 60: 837–844
   PubMed Web of Science ®Google Scholar
• Cox ER, Motheral BR, Henderson RR, Mager D. Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: Results from a commercially insured US sample. Pediatrics 2003; 111: 237–243
   PubMed Web of Science ®Google Scholar
• Duffy A. Does bipolar disorder exist in children? A selected review. Canadian Journal of Psychiatry 2007; 52: 409–417
   PubMed Web of Science ®Google Scholar
• Faraone SV, Sergeant J, Gillberg C, Biederman J. The worldwide prevalence of ADHD: Is it an American condition?. World Psychiatry 2003; 2: 104–113
   PubMedGoogle Scholar
• Fegert JM, Kolch M, Zito JM, Glaeske G, Janhsen K. Antidepressant use in children and adolescents in Germany. Journal of Child and Adolescent Psychopharmacology 2006; 16: 197–206
   PubMed Web of Science ®Google Scholar
• Fombonne E. The prevalence of autism. Journal of the American Medical Association 2003; 289: 87–89
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. FDA approved Risperdal for two psychiatric conditions in children and adolescents. 2007, Available at Website: http://www.fda.gov/bbs/topics/NEWS/2007/NEW01686.html (Accessed on October 29, 2007)
   Google Scholar
• Jensen PS, Mrazek D, Knapp PK, Steinberg L, Pfeffer C, Schowalter, Shapiro T. Evolution and revolution in child psychiatry: ADHD as a disorder of adaptation. Journal of the American Academy of Child and Adolescent Psychiatry 1997; 36: 1672–1679
   PubMed Web of Science ®Google Scholar
• Kessler RC, Frank RG, Edlund M, Katz SJ, Lin E, Leaf P. Differences in the use of psychiatric outpatient services between the United States and Ontario. New England Journal of Medicine 1997; 336: 551–557
   PubMed Web of Science ®Google Scholar
• Kolch M, Schnoor K, Fegert JM. The EU-regulation on medicinal products for paediatric use: Impacts on child and adolescent psychiatry and clinical research with minors. European Child and Adolescent Psychiatry 2007; 16: 229–235
   PubMed Web of Science ®Google Scholar
• Kratochvil CJ, Vitiello B, Walkup J, Emslie G, Waslick BD, Weller EB, et al. SSRIs in pediatric depression: Is the balance between benefits and risks favorable?. Journal of Child and Adolescent Psychopharmacology 2006; 16: 11–24
   PubMedGoogle Scholar
• Kutcher S, Aman M, Brooks SJ, Buitelaar J, van Daalen E, Fegert J, et al. International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): Clinical implications and treatment practice suggestions. European Neuropsychopharmacology 2004; 14: 11–28
   PubMed Web of Science ®Google Scholar
• Lambert KG. Rising rates of depression in today's society: Consideration of the roles of effort-based rewards and enhanced resilience in day-to-day functioning. Neuroscience and Biobehavioral Reviews 2005; 30: 497–510
   PubMed Web of Science ®Google Scholar
• Malhotra S, Kohli A, Arun P. Prevalence of psychiatric disorders in school children in Chandigarh, India. Indian Journal of Medical Research 2002; 116: 21–28
   PubMed Web of Science ®Google Scholar
• Matsuura M, Okubo Y, Kojima T, Takahashi R, Wang YF, Shen YC, et al. A cross-national prevalence study of children with emotional and behavioral problems–A WHO collaborative study in the Western Pacific Region. Journal of Child Psychology and Psychiatry 1993; 34: 307–315
   PubMed Web of Science ®Google Scholar
• Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Archives of General Psychiatry 2007; 64: 1032–1039
   PubMed Web of Science ®Google Scholar
• National Institute for Clinical Excellence. Methylphenidate, atomoxetine and dexamfetamine for attention-deficit hyperactivity disorder (ADHD) in children and adolescents. National Institute for Health and Clinical Excellence (NICE), LondonUK 2006, Technology Appraisal Guidance No. 98
   Google Scholar
• Olfson M, Blanco C, Liu L, Moreno C, Laje G. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry 2006; 63: 679–685
   PubMed Web of Science ®Google Scholar
• Parker G, Gladstone G, Chee KT. Depression in the planet's largest ethnic group: The Chinese. American Journal of Psychiatry 2001; 158: 857–864
   PubMed Web of Science ®Google Scholar
• Polanczyk G, Silva de Lima M, Horta BL, Biederman J, Rohde LA. The wordwide prevalence of ADHD: A systematic review and metaregressino analysis. American Journal of Psychiatry 2007; 164: 942–948
   PubMed Web of Science ®Google Scholar
• Roberts RE, Attkinson CC, Rosenblatt A. Prevalence of psychopathology among children and adolescents. American Journal of Psychiatry 1998; 155: 715–725
   PubMed Web of Science ®Google Scholar
• Santosh PJ, Taylor E, Swanson J, Wigal T, Chuang S, Davies M, et al. Refining the diagnoses of inattention and overactivity syndromes: A reanalysis of the Multimodal Treatment study of attention deficit hyperactivity disorder (ADHD) based on ICD-10 criteria for hyperkinetic disorder. Clinical Neuroscience Research 2005; 5: 307–314
   Web of Science ®Google Scholar
• Scheffler RM, Hinshaw SP, Modrek S, Levine P. The global market for ADHD medications. Health Affairs 2007; 26: 450–457
   PubMed Web of Science ®Google Scholar
• Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, et al. European clinical guidelines for hyperkinetic disorder–first upgrade. European Child Adolescent Psychiatry 2004; 13: 17–30
   Web of Science ®Google Scholar
• Timimi S, Taylor E. ADHD is best understood as a cultural factor. British Journal of Psychiatry 2004; 184: 8–9
   PubMed Web of Science ®Google Scholar
• US Congress. Food and Drug Administration Modernization Act. Public Law No. 105–115 1997
   Google Scholar
• US Congress. Best Pharmaceuticals for Children Act (BPCA). Public Law No. 107–109 2002
   Google Scholar
• US Congress. Pediatric Research Equity Act of 2003. Public Law No. 108–155 2003
   Google Scholar
• Verhulst FC, van der Ende J, Ferdinand RF, Kasius MC. The prevalence of DSM-III-R diagnoses in a national sample of Dutch adolescents. Archives of General Psychiatry 1997; 54: 329–336
   PubMed Web of Science ®Google Scholar
• Vitiello B, Zuvekas S, Norquist DG. National estimates of antidepressant medication use among US children in 1997–2002. Journal of the American Academy of Child and Adolescent Psychiatry 2006; 45: 271–279
   PubMed Web of Science ®Google Scholar
• Vitiello B, Heiligenstein JJ, Riddle MA, Greenhill LL, Fegert JM. The interface between publicly funded and industry-funded research in pediatric psychopharmacology: Opportunities for integration and collaboration. Biological Psychiatry 2004; 56: 3–9
   PubMedGoogle Scholar
• Williams J, Taylor E. The evolution of hyperactivity, impulsivity and cognitive diversity. Journal of the Royal Society Interface 2006; 3: 399–413
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research. WHO, GenevaSwitzerland 1993
   Google Scholar
• WHO. Suicide rates and absolute numbers of suicide by country (2002). 2002, Available at: http://www.who.int/mental_health/prevention/suicide (Accessed October 23, 2007)
   Google Scholar
• WHO World Health Organization Mental Health Survey Consortium. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. Journal of the American Medical Association 2004; 291: 2581–2590
   Google Scholar
• Zito JM, Tobi H, de Jong-van den Berg LTW, Fegert JM, Safer DJ, Janhsen K, et al. Antidepressant prevalence for youths: A multi-national comparison. Pharmacoepidemiology and Drug Safety 2006; 15: 793–798
   PubMedGoogle Scholar
• Zuvekas SH, Vitiello B, Norquist NS. Recent Trends in Stimulant Medication Use among US Children. American Journal of Psychiatry 2006; 163: 579–585
   PubMed Web of Science ®Google Scholar